TG Therapeutics (TGTX) PT Lowered to $20 at Ladenburg Thalmann
Tweet
Share
E-mail
Get Alerts TGTX Hot Sheet
Price: $56.87 +0.71%
Rating Summary:
12 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
12 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Ladenburg Thalmann analyst Matthew Kaplan lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $20.00 (from $47.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Mapletree Logistics Trust (MLT:SP) (MAPGF) to Neutral
- Lasertec Corp. (6920:JP) (LSRCF) PT Raised to JPY41,800 at Nomura/Instinet
- TIME dotCom Berhad (TDC:MK) PT Raised to MYR7.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
